Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.825
Bid: 5.60
Ask: 6.15
Change: 0.00 (0.00%)
Spread: 0.55 (9.821%)
Open: 5.825
High: 0.00
Low: 0.00
Prev. Close: 5.825
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Plant Health Care and Wilbur-Ellis sign Agreement

9 Nov 2020 07:00

RNS Number : 5671E
Plant Health Care PLC
09 November 2020
 

 

RNS

 

 

 

PLANT HEALTH CARE plc

("Plant Health Care" or the "Company")

 

Plant Health Care® and Wilbur-Ellis® Agribusiness enter into Joint-Development Agreement for PREtec products

 

November 9, 2020 - Plant Health Care®, a leading provider of novel patent-protected biological products to global agriculture markets and Wilbur-Ellis® Agribusiness, a recognized leader in precision agriculture, crop protection, seed, nutrition and biological products, announced today they have entered a strategic collaboration for the development of products selected from Plant Health Care's PREtec peptide portfolio.

 

Plant Health Care's plant response elicitor ("PREtec") peptides represent a novel class of technology that stimulate the plant to defend itself. Derived from natural proteins, PREtec is an environmentally friendly approach to protecting crops and increasing yields and is compatible with mainstream agricultural practice. PREtec peptides promote plant health, suppress disease and soil nematodes and increase yield. PREtec may allow farmers to reduce applications of less safe chemical fungicides and achieve better control of damaging plant diseases.

 

Highlights:

 

- Plant Health Care has been developing PHC279 and other peptides that offer substantial benefits to growers in the U.S.

- Wilbur-Ellis, one of the largest U.S. ag retailers, will use its decades of agriculture knowledge and work with Plant Health Care to develop and launch products using PREtec peptides in the specialty crop market.

- Multiple PREtec products are being evaluated by the two companies.

- The first product launches will occur soon after regulatory approvals have been obtained.

 

Wilbur-Ellis, which has an established track record of bringing novel technologies to U.S. growers of specialty crops (fruits, nuts and vegetables), has been working with PREtec over the last growing season to understand how the technology works and where to best position it in the market. Based on that experience, they wish to accelerate their work with Plant Health Care to bring the benefits of these products to U.S. growers. This is intended to be a long-term collaboration to develop a series of products based on PREtec peptides.

 

Multiple PREtec products are being evaluated, initially focusing on improving disease and nematode control, and stress tolerance. The parties are committed to rapidly moving new products through the development process in order to make this novel technology available to growers as soon as possible. This collaboration brings together the development and marketing strengths, as well as decades of agriculture knowledge of Wilbur-Ellis, especially in biological products, with Plant Health Care's industry-leading expertise on PREtec peptides.

 

Chris Richards, CEO of Plant Health Care, said "We are delighted to be working with Wilbur-Ellis to bring the benefits of PREtec peptides to growers of specialty crops. Wilbur-Ellis has been working with our Employ brand (Harpin αβ) for many years and has significantly increased sales since being appointed exclusive distributor for U.S. specialty crops in 2019. They are the ideal partner for us to work with to develop a series of PREtec products in U.S. specialty crops over the coming years, with the first launch as early as the end of 2022, subject to regulatory approvals. This agreement represents an important validation of the commercial value of PREtec as we move to the first product launches. After more than six years and over $20m invested, the benefits of PREtec peptide products will soon be widely available to growers in the U.S. and elsewhere."

 

"Our mission is to maximize the return on investment for our customers," said Wilbur-Ellis Agribusiness President Mark Ripato. "We're looking at numerous paths to deliver those results. We believe the biologicals segment is one of those. Therefore, we are excited to work with Plant Health Care, a globally recognized innovator in this segment, to help us deliver value to the grower in a sustainable way."

 

# # #

About the Wilbur-Ellis Companies 

Founded in 1921, the Wilbur-Ellis companies are leading international marketers and distributors of agricultural products, animal feed, industrial chemicals, specialty chemicals and ingredients. By developing strong relationships, making strategic market investments and capitalizing on new opportunities, the Wilbur-Ellis companies have continued to grow the business with sales now over $3.4 billion. www.wilburellis.com

Wilbur-Ellis' Agribusiness generates more than $2 billion in sales revenue annually and has 160 branch locations throughout the U.S. www.wilburellisagribusiness.com

About Plant Health Care

Plant Health Care offers products to improve the health, vigor and yield of major field crops such as corn, soybeans, potatoes and rice, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors and supply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favorable environmental profile. Company website: www.planthealthcare.com

 

For further information from Plant Health Care plc, please contact:

Chris Richards, CEO Tel: +1 919 926 1600

Arden Partners plc - Nomad & Broker

John Llewellyn-Lloyd / Ben Cryer Tel: +44 (0) 20 7614 5900

 

For further information from Wilbur-Ellis, please contact:

Katherine Fordon, email: Katherine Fordon, (415) 722-4036.

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRZZMGMKVNGGZM
Date   Source Headline
8th Dec 20095:42 pmRNSAdditional Listing
1st Dec 200911:08 amRNSTotal Voting Rights
27th Nov 20092:55 pmRNSDirector/PDMR Shareholding
13th Nov 200911:52 amRNSHolding(s) in Company
10th Nov 20095:29 pmRNSAdditional Listing
6th Nov 200912:53 pmRNSAdditional Listing
4th Nov 20091:52 pmRNSAdditional Listing
2nd Nov 20091:29 pmRNSTotal Voting Rights
1st Oct 20094:21 pmRNSTotal Voting Rights
30th Sep 20095:31 pmRNSDirector/PDMR Shareholding
28th Sep 20096:21 pmRNSAdditional Listing
21st Sep 20099:47 amRNSPosting of Interim Results
21st Sep 20099:41 amRNSAdditional Listing
17th Sep 20096:01 pmRNSAdditional Listing
17th Sep 20095:06 pmRNSAdditional Listing
14th Sep 20097:05 amRNSSustainability Commendation
14th Sep 20097:00 amRNSInterim Results
9th Sep 20097:30 amRNSNotice of Results
1st Sep 200910:19 amRNSTotal Voting Rights
20th Aug 20092:58 pmRNSAdditional Listing
17th Aug 20097:00 amRNSExpansion of Partnership with Scotts
13th Aug 200912:55 pmRNSAdditional Listing
3rd Aug 200910:17 amRNSTotal Voting Rights
28th Jul 20093:05 pmRNSReplacement: Holding(s) in Company
28th Jul 200911:24 amRNSHolding(s) in Company
17th Jul 20091:39 pmRNSAdditional Listing
14th Jul 200912:59 pmRNSDirector/PDMR Shareholding
1st Jul 20097:01 amRNSRe: Monsanto announcement
1st Jul 20097:00 amRNSTotal Voting Rights
25th Jun 20097:00 amRNSSustainable Business 20
9th Jun 20098:35 amRNSDirector/PDMR Shareholding
5th Jun 200910:46 amRNSResult of AGM
4th Jun 20097:00 amRNSTechnical Presentation
3rd Jun 20099:17 amRNSSignificant Shareholding
2nd Jun 20097:00 amRNSMonsanto Order
1st Jun 200911:37 amRNSTotal Voting Rights
1st Jun 20097:00 amRNSEuropean Patent Granted for Harpin
28th May 20095:51 pmRNSAdditional Listing
28th May 20095:23 pmRNSSignificant Shareholding
28th May 20098:47 amRNSHolding(s) in Company
20th May 20099:30 amRNSAdditional Listing
19th May 20098:00 amRNSTest results
18th May 20093:47 pmRNSDirector/PDMR Shareholding
18th May 200910:44 amRNSAdditional Listing
13th May 20091:15 pmRNSDirector/PDMR Shareholding
12th May 200911:53 amRNSEGM Statement
30th Apr 200912:41 pmRNSDirector/PDMR Shareholding
24th Apr 200911:50 amRNSPlacing Announcement
16th Apr 20095:01 pmRNSAnnual Financial Report
15th Apr 20095:20 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.